Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 9
2009 4
2010 10
2011 9
2012 11
2013 10
2014 10
2015 17
2016 31
2017 26
2018 24
2019 22
2020 40
2021 39
2022 28
2023 4
Text availability
Article attribute
Article type
Publication date

Search Results

250 results
Results by year
Filters applied: . Clear all
Page 1
Reply.
Sinn DH, Kang D, Guallar E, Cho J, Gwak GY. Sinn DH, et al. Clin Gastroenterol Hepatol. 2022 Dec 9:S1542-3565(22)01127-2. doi: 10.1016/j.cgh.2022.11.035. Online ahead of print. Clin Gastroenterol Hepatol. 2022. PMID: 36503169 No abstract available.
Reply.
Sinn DH, Kang D, Guallar E, Cho J, Gwak GY. Sinn DH, et al. Hepatology. 2022 Dec;76(6):E121-E122. doi: 10.1002/hep.32678. Epub 2022 Aug 9. Hepatology. 2022. PMID: 35862461 No abstract available.
REPLY.
Goh MJ, Sinn DH, Woo SY, Kim S. Goh MJ, et al. Among authors: sinn dh. Hepatology. 2021 Apr;73(4):1622-1623. doi: 10.1002/hep.31567. Epub 2021 Mar 16. Hepatology. 2021. PMID: 32961603 No abstract available.
Reply.
Goh MJ, Kim S, Woo SY, Sinn DH. Goh MJ, et al. Among authors: sinn dh. Hepatology. 2020 Jun;71(6):2174-2175. doi: 10.1002/hep.31079. Hepatology. 2020. PMID: 31860747 No abstract available.
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B.
Kim HY, Lampertico P, Nam JY, Lee HC, Kim SU, Sinn DH, Seo YS, Lee HA, Park SY, Lim YS, Jang ES, Yoon EL, Kim HS, Kim SE, Ahn SB, Shim JJ, Jeong SW, Jung YJ, Sohn JH, Cho YK, Jun DW, Dalekos GN, Idilman R, Sypsa V, Berg T, Buti M, Calleja JL, Goulis J, Manolakopoulos S, Janssen HLA, Jang MJ, Lee YB, Kim YJ, Yoon JH, Papatheodoridis GV, Lee JH. Kim HY, et al. Among authors: sinn dh. J Hepatol. 2022 Feb;76(2):311-318. doi: 10.1016/j.jhep.2021.09.025. Epub 2021 Oct 2. J Hepatol. 2022. PMID: 34606915
Hepatocellular carcinoma patients with high circulating cytotoxic T cells and intra-tumoral immune signature benefit from pembrolizumab: results from a single-arm phase 2 trial.
Hong JY, Cho HJ, Sa JK, Liu X, Ha SY, Lee T, Kim H, Kang W, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Park HC, Kang TW, Rhim H, Lee SJ, Cristescu R, Lee J, Paik YH, Lim HY. Hong JY, et al. Among authors: sinn dh. Genome Med. 2022 Jan 6;14(1):1. doi: 10.1186/s13073-021-00995-8. Genome Med. 2022. PMID: 34986867 Free PMC article. Clinical Trial.
250 results